Allergic Rhinitis
Conditions
Interventions
Control Group:Mometasone nasal spray
Experimental Group:Mometasone nasal spray + acupoint patching
Sponsors
South China University of Integrated Chinese and Western Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Meets the diagnostic criteria for allergic rhinitis 2) Aged between 18 and 65 years 3) Voluntarily agrees to participate in this trial and is able to adhere to the treatment and observation for 2 weeks 4) No use of medications related to nasal diseases within the past 2 weeks prior to the start of this trial.
Exclusion criteria
Exclusion criteria: 1. Patients with other respiratory system diseases; 2. Patients with severe diseases of the heart, brain, liver, kidney, or hematopoietic system requiring long-term medication; 3. Patients who have used glucocorticoids or immunosuppressive agents within the past month; 4. Patients who are intolerant to the treatment used in this study; 5. Pregnant or breastfeeding women; 6. Patients with allergic reactions to the traditional Chinese medicine or adhesive used in this trial, or those with eczema, dermatitis, or other skin diseases; 7. Patients with severe mental illness who are unable to provide a detailed and complete description of their condition or lack full capacity for independent action; 8. Patients with acute or chronic infectious diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasal Symptom Total Integral Score Table Total Nasal Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Assessment;Serum IgE level;Comprehensive Efficacy Evaluation; | — |
Countries
China
Contacts
Public ContactChen Jing
South China University of Integrated Chinese and Western Medicine Hospital
Outcome results
None listed